Institutional members access full text with Ovid®

Share this article on:

Associations between variants in theABCB1(MDR1) gene and corticosteroid dependence in children with Crohn's disease

Krupoves, Alfreda MD1,2; Mack, David MD3; Seidman, Ernest MD4; Deslandres, Colette MD1; Amre, Devendra PhD1,5,*

doi: 10.1002/ibd.21608
Original Article: Original Clinical Articles

Background: Corticosteroids (CS) effectively induce remission in patients with moderate to severe Crohn's disease (CD). However, CS dependence in children is a significant clinical problem associated with numerous side effects. Identification of molecular markers of CS dependence is of paramount importance. The ABCB1 gene codes for P-glycoprotein, a transporter involved in the metabolism of CS. We examined whether DNA variation in the ABCB1 gene was associated with CS dependency in children with CD.

Methods: A retrospective study was carried out in two Canadian tertiary pediatric gastroenterology centers. Clinical information was abstracted from medical charts of CD patients (N = 260) diagnosed with CD prior to age 18 and administered a first course of CS during the 1 year since diagnosis. Patients were classified as CS-dependent if they relapsed during drug tapering or after the end of therapy. DNA was extracted from blood or saliva. Thirteen tagging single nucleotide polymorphisms (tag-SNPs) and a synonymous variation (C3435T) in the ABCB1 gene were genotyped. Allelic, genotype, and haplotype associations were examined using logistic regression and Haploview.

Results: Tag-SNP rs2032583 was statistically significantly associated with CS dependency. The rare C allele of this SNP (odds ratio [OR] = 0.56, 95% confidence interval [CI]: 0.34–0.95, P = 0.029) and heterozygous genotype TC (OR = 0.52, 95% CI: 0.28–0.95, P = 0.035) conferred protection from CS dependency. A three-marker haplotype was significantly associated with CS dependence (multiple comparison corrected P-value = 0.004).

Conclusions: Our results suggest that the ABCB1 gene may be associated with CS dependence in pediatric CD patients. (Inflamm Bowel Dis 2011;)

1Research Centre, Ste-Justine Hospital, Montreal, Quebec, Canada

2Department of Preventive & Social Medicine, University of Montreal, Montreal, Quebec, Canada

3Division of Gastroenterology, Hepatology & Nutrition, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada

4Department of Medicine, Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

5Department of Paediatrics, University of Montreal, Montreal, Quebec, Canada

*Reprints: Research Centre, Bureau A-728, Ste-Justine Hospital, 3175 Cote-Sainte-Catherine, Montreal, QC, H3T 1C5 Canada

Email: devendra.amre@umontreal.ca

Received 30 October 2010; Accepted 10 November 2010

Published online 6 January 2011 in Wiley Online Library (wileyonlinelibrary.com).

Dr. Krupoves is supported by a scholarship from the Sainte-Justine Hospital Foundation and by a scholarship of the PhD Program of the University of Montreal. This research was supported by the Canadian Institutes of Health Research (MOP 86609), the Canadian Institutes of Health Research, IBD-Net Grant, Infection and Immunity, and the Sainte-Justine Hospital Foundation.

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website